The CRASH trial protocol (corticosteroid randomisation after significant head injury) [ISRCTN74459797]

BMC Emergency Medicine

Volumn 1, Issue , 2001, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CORTICOSTEROID; METHYLPREDNISOLONE; PLACEBO;

ADOLESCENT; ADULT; ANAPHYLAXIS; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG DOSE REGIMEN; DRUG INFUSION; EMERGENCY WARD; GASTROINTESTINAL HEMORRHAGE; HEAD INJURY; HEALTH CARE MANAGEMENT; HUMAN; INFECTION; INFORMED CONSENT; MEDICAL RECORD; NEUROLOGIC DISEASE; NURSE; PHYSICIAN; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; TREATMENT OUTCOME; UNCONSCIOUSNESS;

EID: 34548144826     PISSN: 1471227X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-227X-1-1     Document Type: Article

References (15)

1. Jennett B, Teasdale G: Management of head injuries. Philadelphia. FA Davies, 1981
2. Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet 1975, 1:480-484
3. Alderson P, Roberts I: Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials. BMJ 1997, 314:1855-1859
4. Bracken MB, Shepard MJ, Collins WF, et al: A randomised controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. N Eng J Med 1990, 322:1405-1411
5. Otani K, Abe H, Kadoya S, et al: Beneficial effect of methylprednisolone sodium succinate in the treatment of acute spinal cord injury (translation of Japanese). Sekitsui Sekizui J 1994, 7:633-647
6. Bracken MB, Shepard MJ, Holford TR, et al: Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997, 277:1597-1604
7. Demopoulos HB, Flamm ES, Seligman ML: Further studies on free radical pathology in the major central nervous system disorders: effects of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury. Can J Physiol Pharmacol 1982, 60:1415-1424
8. Anderson DK, Saunders RD, Demediuk P: Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium. Central Nervous System Trauma 1985, 2:257-267
9. Braughler JM, Hall ED, Means ED, et al: Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury. J Neurosurg 1987, 67:102-105
10. Hall ED: High dose glucocorticoid treatment improves neurological recovery in head-injured mice. J Neurosurg 1985, 62:882-887
11. Hall ED: The neuroprotective pharmacology of methylprednisolone. J. Neurosurg 1992, 76:13-22
12. Gaab MR, Trost HA, Alcantara A, et al: Ultrahigh dexamethasone in acute brain injury. Results from a prospective randomised double-blind multi-centre trial. Zentralblatt für Neurochirurgie 1994, 55:135-143
13. Collins R, Doll R, Peto R: Ethics of clinical trials. In: Williams C, ed. Introducing New Treatments for Cancer. Chichester: John Wiley and Sons Ltd, 1991
14. Ewan PW: Treatment of anaphylactic reactions. Prescribers' Journal 1997, 37:125-132
15. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomised clinical trials requiring prolonged observation of each patient. 1. Introduction and design. Br J Cancer 1976, 34:585-612